Name: Latest research reports of Alkem Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

5581.5000 57.50 (1.04%)

NSE Oct 17, 2025 15:31 PM

Volume: 65,056

Alkem Laboratories Ltd.

10 Feb 2024

5581.50

1.04%

Alkem Labs (SELL): Good quarter; cut to SELL on stretched valuations

Sell: Alkem Laboratories Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Revenue grew 9% YoY in Q3 backed by strong India and ROW growth that offset lower US business

Number of FII/FPI investors increased from 551 to 589 in Sep 2025 qtr.